Here you can find news from MPG spin-off companies.
Cardior announces positive results of its phase Ib study of the active ingredient CDR132L for the treatment of cardiovascular diseases.
Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs That Target Biomolecular Condensates
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
Evotec and BIOASTER partner to build a technology and innovation hub in Lyon